These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11789675

  • 21. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery.
    Karathanasis E, Ayyagari AL, Bhavane R, Bellamkonda RV, Annapragada AV.
    J Control Release; 2005 Mar 02; 103(1):159-75. PubMed ID: 15710508
    [Abstract] [Full Text] [Related]

  • 22. Particle size-dependent triggering of accelerated blood clearance phenomenon.
    Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N.
    Int J Pharm; 2008 Oct 01; 362(1-2):197-200. PubMed ID: 18586076
    [Abstract] [Full Text] [Related]

  • 23. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
    Merdan T, Kunath K, Petersen H, Bakowsky U, Voigt KH, Kopecek J, Kissel T.
    Bioconjug Chem; 2005 Oct 01; 16(4):785-92. PubMed ID: 16029019
    [Abstract] [Full Text] [Related]

  • 24. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
    Tagami T, Nakamura K, Shimizu T, Yamazaki N, Ishida T, Kiwada H.
    J Control Release; 2010 Mar 03; 142(2):160-6. PubMed ID: 19850094
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):185-94. PubMed ID: 9735159
    [Abstract] [Full Text] [Related]

  • 26. Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
    Sroda K, Rydlewski J, Langner M, Kozubek A, Grzybek M, Sikorski AF.
    Cell Mol Biol Lett; 2005 Sep 15; 10(1):37-47. PubMed ID: 15809678
    [Abstract] [Full Text] [Related]

  • 27. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.
    Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N, Shinohara A, Eriguchi M, Yanagie H, Maruyama K.
    Int J Pharm; 2008 Jan 04; 346(1-2):143-50. PubMed ID: 17640835
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
    Heyes J, Hall K, Tailor V, Lenz R, MacLachlan I.
    J Control Release; 2006 May 15; 112(2):280-90. PubMed ID: 16603272
    [Abstract] [Full Text] [Related]

  • 29. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT, Mészáros T, Vashegyi I, Fülöp T, Örfi E, Dézsi L, Rosivall L, Bavli Y, Urbanics R, Mollnes TE, Barenholz Y, Szebeni J.
    ACS Nano; 2019 Aug 27; 13(8):9315-9324. PubMed ID: 31348638
    [Abstract] [Full Text] [Related]

  • 30. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
    Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S.
    Adv Drug Deliv Rev; 2004 Apr 29; 56(8):1177-92. PubMed ID: 15094214
    [Abstract] [Full Text] [Related]

  • 31. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate.
    Yang Z, Sun X, Li S, Tan Y, Wang X, Zhang N, Yagi S, Takakura T, Kobayashi Y, Takimoto A, Yoshioka T, Suginaka A, Frenkel EP, Hoffman RM.
    Cancer Res; 2004 Aug 15; 64(16):5775-8. PubMed ID: 15313919
    [Abstract] [Full Text] [Related]

  • 32. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
    Judge A, McClintock K, Phelps JR, Maclachlan I.
    Mol Ther; 2006 Feb 15; 13(2):328-37. PubMed ID: 16275098
    [Abstract] [Full Text] [Related]

  • 33. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
    Szebeni J.
    Crit Rev Ther Drug Carrier Syst; 2001 Feb 15; 18(6):567-606. PubMed ID: 11789676
    [Abstract] [Full Text] [Related]

  • 34. Liposomes for scintigraphic imaging: optimization of in vivo behavior.
    Boerman OC, Oyen WJ, Corstens FH, Storm G.
    Q J Nucl Med; 1998 Dec 15; 42(4):271-9. PubMed ID: 9973842
    [Abstract] [Full Text] [Related]

  • 35. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.
    J Control Release; 2004 Aug 11; 98(2):195-207. PubMed ID: 15262412
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S, Vali AM, Rezaie M.
    Int J Pharm; 2008 Apr 02; 353(1-2):251-9. PubMed ID: 18191511
    [Abstract] [Full Text] [Related]

  • 38. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.
    Ishida T, Harada M, Wang XY, Ichihara M, Irimura K, Kiwada H.
    J Control Release; 2005 Jul 20; 105(3):305-17. PubMed ID: 15908032
    [Abstract] [Full Text] [Related]

  • 39. The interaction of liposomes with the complement system.
    Szebeni J.
    Crit Rev Ther Drug Carrier Syst; 1998 Jul 20; 15(1):57-88. PubMed ID: 9523086
    [Abstract] [Full Text] [Related]

  • 40. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
    Yang Z, Wang J, Lu Q, Xu J, Kobayashi Y, Takakura T, Takimoto A, Yoshioka T, Lian C, Chen C, Zhang D, Zhang Y, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Hoffman RM.
    Cancer Res; 2004 Sep 15; 64(18):6673-8. PubMed ID: 15374983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.